We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLO icon
276
Flowers Foods
FLO
$1.56B
$664K 0.11%
23,115
-25,429
-52% -$714K
CHH icon
277
Choice Hotels
CHH
$5.14B
$656K 0.11%
5,824
-871
-13% -$104K
CSX icon
278
CSX Corp
CSX
$94.4B
$653K 0.11%
21,088
-62,799
-75% -$1.89M
BMRN icon
279
BioMarin Pharmaceuticals
BMRN
$11.7B
$652K 0.11%
6,297
-19,026
-75% -$1.79M
HRMY icon
280
Harmony Biosciences
HRMY
$2.24B
$652K 0.11%
11,826
+6,038
+104% +$332K
CNQ icon
281
Canadian Natural Resources
CNQ
$95.1B
$650K 0.11%
+23,420
New +$669K
FRC
282
DELISTED
First Republic Bank
FRC
$639K 0.11%
+5,240
New +$639K
VIRT icon
283
Virtu Financial
VIRT
$5.23B
$629K 0.11%
30,800
+11,546
+60% +$251K
ARES icon
284
Ares Management
ARES
$31.3B
$622K 0.11%
+9,089
New +$656K
LSCC icon
285
Lattice Semiconductor
LSCC
$18.3B
$621K 0.11%
9,574
+3,647
+62% +$220K
BPOP icon
286
Popular Inc
BPOP
$11.3B
$619K 0.11%
+9,334
New +$649K
SHLS icon
287
Shoals Technologies Group
SHLS
$1.52B
$618K 0.1%
25,062
+1,795
+8% +$43.3K
HOG icon
288
Harley-Davidson
HOG
$2.78B
$612K 0.1%
+14,708
New +$626K
GTLB icon
289
GitLab
GTLB
$6.13B
$605K 0.1%
+13,307
New +$601K
WCC
290
WESCO International
WCC
$18.4B
$603K 0.1%
4,818
-1,533
-24% -$193K
ATI icon
291
ATI
ATI
$27.9B
$603K 0.1%
20,180
-20,791
-51% -$609K
D icon
292
Dominion Energy
D
$60.1B
$598K 0.1%
+9,746
New +$612K
TXRH icon
293
Texas Roadhouse
TXRH
$13.8B
$592K 0.1%
6,514
+2,234
+52% +$215K
AXSM icon
294
Axsome Therapeutics
AXSM
$10.9B
$591K 0.1%
+7,662
New +$458K
DTE icon
295
DTE Energy
DTE
$29B
$585K 0.1%
+4,978
New +$564K
SM icon
296
SM Energy
SM
$7.15B
$581K 0.1%
16,687
-4,581
-22% -$190K
NVR icon
297
NVR
NVR
$17B
$581K 0.1%
+126
New +$554K
TREX icon
298
Trex
TREX
$5.11B
$575K 0.1%
13,576
+4,816
+55% +$219K
ECL icon
299
Ecolab
ECL
$79.7B
$574K 0.1%
3,943
-2,401
-38% -$353K
FSK icon
300
FS KKR Capital
FSK
$3.09B
$571K 0.1%
32,600
+15,507
+91% +$288K
10 11
12
13 14

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.